Nagoya, Japan

Satoru Sugiyama

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1997-2010

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Satoru Sugiyama

Introduction

Satoru Sugiyama, an influential inventor based in Nagoya, Japan, has made significant contributions to the field of medical innovations. With a portfolio of five patents, Sugiyama focuses on developing groundbreaking solutions for various health issues.

Latest Patents

Among his latest inventions, Sugiyama has been instrumental in creating a hepatic fibrosis inhibitor, which targets the progression of hepatic fibrosis and cirrhosis caused by various liver disorders. This innovative inhibitor contains a compound defined by a specific chemical formula, featuring an alkyl group with carbons ranging from 4 to 8. In addition, his anti-inflammatory analgesic preparation contains a unique 3-0-substituted ascorbic acid as an active ingredient, demonstrating remarkable anti-inflammation and analgesic effects, alongside an impressive shelf life and skin safety profile.

Career Highlights

Throughout his career, Sugiyama has collaborated with notable organizations, including Teijin Limited and Nippon Hypox Laboratories Inc. His work in these esteemed companies has elevated his status as a respected figure in the field of biomedical innovation.

Collaborations

Sugiyama has had the opportunity to work alongside esteemed colleagues, such as Takayuki Ozawa and Shigehisa Kitahara. These collaborations have fostered a stimulating environment for creativity and advancement in the realm of medical inventions.

Conclusion

Satoru Sugiyama exemplifies the spirit of innovation through his contributions to healthcare-related inventions. His relentless pursuit of solutions for medical challenges showcases the vital role inventors play in improving lives and advancing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…